Menu Close

Signals of symptom benefit or symptom burden can be included early in the development of a drug to guide the development of dosing recommendations and needed supportive care and to inform potential providers and patient consumers along with those who must approve the agent and those who will determine whether or not to pay for it

Signals of symptom benefit or symptom burden can be included early in the development of a drug to guide the development of dosing recommendations and…